Company intelligence / Profile preview

EmCyte

Fort Myers, Florida, United States

Ownership: Private
Development stage: Other

Overview

EmCyte Corporation develops and commercializes platforms enabling physicians to prepare platelet-rich plasma and stem cell concentrates from a patient's own blood for clinical use in regenerative medicine. Their systems are FDA 510(k) cleared. Clinical cases cite improvements in healing and tissue repair, though peer-reviewed clinical trial data volume is not specified.

Therapeutic areas: OtherDermatology
Modalities: Cell therapyDeviceBiologic
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on EmCyte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EmCyte.

Explore the full profile